๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
NCT06434597Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
60
Beijing, Changsha, Changzhi, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei
2024-07-17
Recruiting
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
NCT06571825Acute Myeloid Leukemia
He Huang
Phase 4
118
Hangzhou
2024-07-17
Recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580Generalized Myasthenia Gravis
Vor Biopharma
Phase 3
180
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Zunyi, Wuhan
2024-07-17
Recruiting
IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus
NCT06380868Diabetes
Nanjing First Hospital, Nanjing Medical University
Not applicable
1,332
Nanjing
2024-07-17
Recruiting
Peginterferon ฮฑ-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia
NCT06881056Respiratory Syncytial Virus (RSV)
West China Second University Hospital
Not applicable
90
Chengdu
2024-07-17
Recruiting
Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial
NCT07103980Post-Infectious Cough
Shanghai Changzheng Hospital
Phase 1/2
40
Shanghai
2024-07-16
Recruiting
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
NCT06504290Schizophrenia
Vigonvita Life Sciences
Phase 1
40
Beijing, Xiโ€™an
2024-07-16
Recruiting
Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
NCT06791226Orbital Neoplasms
Peking University Third Hospital
Not applicable
50
Beijing
2024-07-16
Recruiting
Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety
NCT06531278Pancreatic Cancer Metastatic to Liver
Jiang Long
Phase 2
40
Shanghai
2024-07-16
Active, closed
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
NCT06456346Essential Thrombocythemia
Merck Sharp & Dohme LLC
Phase 3
300
Bengbu, Hefei, Beijing, Chongqing, Quanzhou, Xiamen, Guangzhou, Shijiazhuang
2024-07-16
Recruiting
Choroidal and Retinal Features in PACD and POAG on OCT and OCTA
NCT07580014Glaucoma, OCTA, Choroid
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
132
Guangzhou
2024-07-16
Recruiting
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
NCT06496373Pancreatic Cancer Resectable, Chemotherapy-intolerant
Ruijin Hospital
Phase EARLY_PHASE1
20
Shanghai
2024-07-16
Recruiting
Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria
NCT06687733Phenylketonurias
NGGT (Suzhou) Biotechnology Co., Ltd.
Phase 1/2
18
Bengbu, Shanghai
2024-07-16
Recruiting
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
NCT06453902Chronic Myeloid Leukemia, Accelerated Phase CML
Shenzhen TargetRx Co., Ltd.
Phase 2
40
Beijing
2024-07-15
Recruiting
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
NCT06491472Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
36
Wuhan
2024-07-15
By invitation
Constructing a Risk Prediction Model for Intraoperative Hypothermia in Children Under General Anesthesia
NCT06892795Hypothermia, Accidental, Hypothermia; Anesthesia
Harbin Medical University
Observational
562
Harbin
2024-07-15
Recruiting
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
NCT06197776Multi-omics Technique, Nasopharyngeal Carcinoma, Recurrent and Metastatic Nasopharyngeal Carcinoma, Efficacy of Chemoradiotherapy and Immunotherapy
Sun Yat-sen University
Observational
50
Guangzhou
2024-07-15
Recruiting
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
NCT06323239Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
148
Guangzhou
2024-07-15
Active, closed
Clinicopathological Features and Genetic Susceptibility Screening of Recurrent Drug-induced Liver Injury
NCT06547229Recurrent Drug-induced Liver Injury
Beijing Friendship Hospital
Observational
60
Beijing
2024-07-15
Recruiting
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
NCT06534762NSCLC, SCLC, Colorectal Cancer, Pancreas Cancer
Zhejiang Provincial People's Hospital
Phase 2
260
Hangzhou
2024-07-15
Not yet open
Remimazolam Besylate and Propofol Sedation on Hemodynamic for Coronary Artery Bypass Graft Patients
NCT06496165Coronary Artery Disease
Shanghai Zhongshan Hospital
Not applicable
338
Shanghai
2024-07-15
Recruiting
Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy
NCT06559696Breast Cancer
Fujian Medical University Union Hospital
Phase 3
722
Fuzhou
2024-07-15
Not yet open
Prospective Observational Cohort Study
NCT06493448Gastric Cancer, Liver Metastases
Lin Chen
Observational
1,326
Beijing
2024-07-15
Not yet open
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
NCT06499610Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
44
Xi'an
2024-07-15
Recruiting
Furmonertinib 160mg as First-line Treatment in Locally Advanced or Metastatic NSCLC With EGFR Classical Mutations
NCT06674343Advanced or Metastatic Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 3
144
Beijing
2024-07-15
Recruiting
GOS and the Management of Hyperuricemia
NCT06630377Subjects With Hyperuricemia
Sun Yat-sen University
Not applicable
70
Guangzhou
2024-07-15
Recruiting
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
NCT06511349Type 1 Primary Hyperoxaluria
RenJi Hospital
Phase EARLY_PHASE1
21
Shanghai
2024-07-15
Recruiting
Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
NCT06503380Hematological Toxicity, Targeted Therapy, Breast Cancer
Fudan University
Observational
1,000
Shanghai
2024-07-15
Recruiting
Modified Aortic Root Enlargement Procedure
NCT06517537Small Aortic Annulus, Aortic Root Enlargement Procedure
China National Center for Cardiovascular Diseases
Observational
64
Beijing
2024-07-15
Recruiting
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
NCT06520397Crohn Disease
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 4
214
Guangzhou
2024-07-15
Recruiting
The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population
NCT06510205Breast Augmentation, Mammaplasty
Johnson & Johnson Medical (Shanghai) Ltd.
Observational
6,111
Chengdu, Kunming, Shenzhen
2024-07-14
Recruiting
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
NCT06429696Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University
Phase 2
40
Guangzhou
2024-07-14
By invitation
Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage
NCT06519617Primary Sjรถgren Syndrome
Qingwen Tao
Phase 2
136
Beijing
2024-07-13
Recruiting
Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children
NCT06500078Cardiovascular Syndrome, Metabolic
Children's Hospital of Fudan University
Not applicable
324
Shanghai
2024-07-13
Active, closed
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older
NCT06447779Herpes Zoster
MAXVAX Biotechnology Limited Liability Company
Phase 3
25,000
Shijiazhuang, Zhengzhou, Wuhan, Kunming
2024-07-13
Recruiting
High-Intensity Interval Training(HIIT) on Cardio-metabolic Risk in School-age Children
NCT06416488Cardiovascular Syndrome, Metabolic
Children's Hospital of Fudan University
Not applicable
336
Shanghai
2024-07-13
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
109
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan, Nanchang
2024-07-12
Recruiting
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
NCT06371040Myasthenia Gravis
Ting Chang, MD
Phase 1
9
Xi'an
2024-07-12
Active, closed
Efficacy of PD-1 Monoclonal Antibody in the Treatment of Phaeohyphomycosis
NCT06796231Phaeohyphomycosis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
1
Guangdong
2024-07-12
Recruiting
A Clinical Study of B007 in the Treatment of Pemphigus.
NCT06454357Pemphigus
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2/3
132
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Jinan, Shanghai
2024-07-12
Recruiting
Predictive Value of Tumor Microenvironment PET/CT for Response and Prognosis in Aggressive Lymphoma: A Multicenter Study
NCT07657494Aggressive Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
94
Beijing
2024-07-11
Recruiting
Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis
NCT06462417Allergic Rhinitis
Zheng Liu
Not applicable
15
Wuhan
2024-07-11
Recruiting
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
NCT06601309Esophageal Squamous Cell Carcinoma
Fujian Medical University Union Hospital
Phase 2
90
Fuzhou
2024-07-11
Recruiting
A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
NCT06434610Platinum-resistant Recurrent Ovarian Cancer
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 2
90
Beijing, Bengbu, Changsha, Fuzhou, Guangzhou, Jinan, Kunming, Nanning
2024-07-11
Recruiting
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4๏ผ‰
NCT06319846Ischemic Stroke, Acute, TIA, Symptomatic Intracranial Artery Stenosis
Beijing Tiantan Hospital
Phase 3
4,674
Harbin, Dezhou, Liaocheng, Yantai
2024-07-11
Recruiting
A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer
NCT06383767Metastatic Breast Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3
378
Beijing
2024-07-11
Active, closed
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
NCT06445023Chronic Spontaneous Urticaria
Celldex Therapeutics
Phase 3
963
2024-07-11
Recruiting
Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas
NCT06513234Marginal Zone Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
45
Tianjin
2024-07-11
Active, closed
JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer๏ผˆNSCLC๏ผ‰
NCT06505837Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
395
Changshang
2024-07-11
Active, closed
Exploring the Efficacy of a Breathing Training Intervention in Patients With Emotionally Regulated Sleep Disorders
NCT07495423Sleep Disorder (Disorder), Mood Disorders
Qilu Hospital of Shandong University
Not applicable
188
Jinan
2024-07-11
Active, closed
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
NCT06465914Genital Wart, Penile Cancer, Anal Cancer, PIN-1
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3
9,000
Nanning, Changsha, Taiyuan, Chengdu, Kunming
2024-07-11
Recruiting
Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients
NCT06212076Solid Tumor
Nanjing Immunophage Biotech Co., Ltd
Phase 1/2
60
Shanghai
2024-07-11
Recruiting
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
NCT06558981Thyroid Cancer
Fudan University
Phase 3
124
Shanghai
2024-07-11
Recruiting
Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
NCT06471738Ann Arbor Stage II Follicular Lymphoma, Grade 1 Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma
Chinese PLA General Hospital
Phase 2
30
Beijing
2024-07-10
Recruiting
Bendamustine and Rituximab With or Without Orelabrutinib in MCL Treatment
NCT06496308Mantle Cell Lymphoma (MCL)
Ruijin Hospital
Phase 3
78
Shanghai
2024-07-10
Recruiting
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
NCT06791148Gastric Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
45
Nanjing
2024-07-10
Active, closed
Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema
NCT06498050Diabetic Macular Edema
Guangdong Provincial People's Hospital
Phase 4
52
Guangzhou
2024-07-10
Recruiting
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
NCT06387628TNBC - Triple-Negative Breast Cancer
Fudan University
Phase 2
74
Shanghai
2024-07-10
Recruiting
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
NCT06650332Metastatic HER2 Positive Gastroesophageal Junction Cancer
Zhejiang Cancer Hospital
Phase 1/2
90
Hangzhou
2024-07-10
Not yet open
A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT06487702Esophageal Squamous Cell Carcinoma
Rui-hua Xu, MD, PhD
Phase 2
70
Guangzhou
2024-07-10
Recruiting
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells
NCT06420076T Cell Lymphoma, T Cell Leukemia, T-cell Acute Lymphoblastic Leukemia, T-Cell Lymphoma of CNS
Essen Biotech
Phase 1/2
60
Beijing
2024-07-10
Active, closed
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
NCT06254014Type 2 Diabetes Mellitus
Beijing Dongfang Biotech Co., Ltd.
Phase 3
270
Beijing
2024-07-10
Recruiting
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
NCT06350110Systemic Lupus Erythematosus, Lupus Nephritis, Autoimmune Diseases, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Essen Biotech
Phase 1/2
75
Beijing
2024-07-10
Recruiting
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
NCT06213636Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin Lymphoma, B-cell, Diffuse Large B Cell Lymphoma
Essen Biotech
Phase 1/2
75
Beijing
2024-07-10
Recruiting
Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NCT06827938Warts
First Hospital of China Medical University
Not applicable
400
Shenyang
2024-07-10
Recruiting
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
NCT06420063AML, Acute Myeloid Leukemia, AML, Adult Recurrent, AML, Adult
Essen Biotech
Phase 1/2
85
Beijing
2024-07-10
Recruiting
A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
NCT06548958Malignant Hematological Diseases
The First Affiliated Hospital of Soochow University
Not applicable
40
Suzhou
2024-07-10
Recruiting
A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
NCT07532486Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hangzhou
2024-07-10
Active, closed
FIH of PFBalloon for PVI
NCT07320976Paroxysmal Atrial Fibrillation
The Third People's Hospital of Chengdu
Not applicable
35
Chengdu
2024-07-10
Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
NCT06024746Heart Failure
Colorado Prevention Center
Phase 3
1,500
Guangzhou, Changsha, Jinan, Shanghai, Taiyuan, Xian City, Chengdu, Tianjin
2024-07-09
Recruiting
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
NCT06500676KRAS G12D Mutations, Advanced Solid Tumors
Genfleet Therapeutics (Shanghai) Inc.
Phase 1/2
407
Hefei, Beijing, Guangzhou, Nanning, Haerbin, Zhengzhou, Wuhan, Changsha
2024-07-09
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
NCT06127407Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Servier Bio-Innovation LLC
Phase 3
136
Guangzhou, Wuhan, Shang'ai, Shanghai, Chengdu, Hangzhou, Beijing
2024-07-09
Active, closed
Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
NCT06452537Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Tianjin Medical University General Hospital
Phase 2/3
102
Hefei, Lanzhou, Shijiazhuang, Harbin, Zhenzhou, Ordos, Changzhou, Suzhou
2024-07-09
Recruiting
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
NCT06235203Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 3
154
Shanghai, Fuzhou, Nanning, Shenzhen
2024-07-09
Active, closed
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
NCT06372925Plaque, Atherosclerotic
Novartis Pharmaceuticals
Phase 4
318
Hefei, Fuzhou, Guangzhou, Shenzhen, Zunyi, Harbin, Zhengzhou, Wuhan
2024-07-09
Active, closed
Efficacy and Safety of Colchicine After PCI
NCT06472908Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3
8,862
Hefei, Beijing, Chongqing, Xiamen, Lanzhou, Harbin, Zhengzhou, Enshi
2024-07-09
Recruiting
TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies
NCT06484816Non Small Cell Lung Cancer, Advanced Solid Tumor, Hematologic Malignancy
Shenzhen TargetRx Co., Ltd.
Phase 1
90
Hangzhou
2024-07-08
Recruiting
Association Between Local Cerebral Oxygenation Monitoring and Postoperative Stroke in Carotid Endarterectomy
NCT06406842Carotid Endarterectomy, Cerebral Autoregulation
Beijing Tiantan Hospital
Not applicable
560
Beijing
2024-07-08
Recruiting
Effectiveness of Integrative Medical Treatment in Sudden Hearing Loss
NCT07235488Sudden Hearing Loss
China Medical University Hospital
Not applicable
64
2024-07-08
Recruiting
CMOPยฑR in the Treatment of Untreated Non-Hodgkin's Lymphoma
NCT06486337NHL
The First Affiliated Hospital of Soochow University
Phase 2
197
Suzhou
2024-07-08
Recruiting
Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML
NCT06621199Acute Myeloid Leukemia
First Affiliated Hospital of Zhejiang University
Phase 2
42
Hangzhou
2024-07-08
Recruiting
Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG
NCT06524479Refractory Epilepsy, Sleep
Xuanwu Hospital, Beijing
Not applicable
20
Beijing
2024-07-08
Recruiting
Natural History of Coronary Atherosclerosis
NCT06040073Coronary Artery Disease Progression, Radial Wall Strain, Atherosclerotic Lesion, Optical Coherence Tomography
China National Center for Cardiovascular Diseases
Observational
125
Beijing
2024-07-07
Recruiting
Single-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease (MOOP-CAD)
NCT06489119Coronary Artery Disease
Harbin Medical University
Observational
350
Harbin, Changchun
2024-07-07
Recruiting
Effect of Different Cold Therapy Programs in Patients Received Total Knee Arthroplasty Operation
NCT07021287Total Knee Arthroplasty
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
260
Yiwu
2024-07-06
Not yet open
RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer
NCT06492317HER2-positive Gastric Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2
20
Zhengzhou
2024-07-06
Active, closed
Paired Emotion Reading Improves Emotion Regulation in Rural Children With ACE
NCT06505629Emotion Regulation, Adverse Childhood Experience
Peking University
Not applicable
150
Beijing
2024-07-06
By invitation
The Effects of Kefir on Pediatric Obesity
NCT06500104Obesity
China Medical University Hospital
Not applicable
60
2024-07-06
Recruiting
A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease
NCT06818838Gaucher Disease Type 1
Lingyi Biotech Co., Ltd.
Phase 1/2
12
Guangzhou, Taiyuan, Tianjin
2024-07-05
Recruiting
To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
NCT06808412Rcctal Cancer
xiaohua li
Phase 2
118
Xi'an
2024-07-05
By invitation
Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults
NCT06782958Amyotrophic Lateral Sclerosis (ALS)
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Phase 1
72
Lanzhou
2024-07-05
Active, closed
A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.
NCT06392724Duchenne Muscular Dystrophy (DMD)
Peking Union Medical College Hospital
Phase EARLY_PHASE1
3
Beijing
2024-07-05
Active, closed
A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
NCT06385678Advanced KRAS G12D Mutant Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
47
Shanghai
2024-07-05
Recruiting
Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
NCT06621212Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy
First Affiliated Hospital of Zhejiang University
Phase 2
72
Hangzhou
2024-07-05
Recruiting
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
NCT07250542Prostate Cancer
baotai Liang
Phase 2
30
Nanjing
2024-07-05
Recruiting
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours
NCT06453057Adult
Grit Biotechnology
Not applicable
18
Shanghai
2024-07-04
Active, closed
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
NCT06462469Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals
Phase 4
36
Guangzhou, Zhengzhou, Wuhan, Xian, Hangzhou, Beijing, Taian, Tianjin
2024-07-04
Recruiting
The Effect of Serum Ferritin in irAE
NCT06702566Immune-related Adverse Event, Malignant Solid Tumors, Acute Leukemia, Serum Ferritin
Tianjin Medical University Cancer Institute and Hospital
Not applicable
1,500
Tianjin
2024-07-04
Recruiting
Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine
NCT06528197Primary Sjรถgren Syndrome
China-Japan Friendship Hospital
Observational
1,000
Beijing
2024-07-04
Recruiting
A Study of SKB518 in Patients With Advanced Solid Tumors
NCT06428331Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
150
Shanghai
2024-07-04
Rows per page Showing 12201–12300 of 19052
Previous 121 122 123 124 125 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=123

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.